Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 09-2005 | 06-2005 | |
| Sales | 2,539 | 1,689 | 1,105 | 284 | 0 |
| Cost of Goods | 1,113 | 762 | 489 | 220 | N/A |
| Gross Profit | 1,426 | 927 | 616 | 64 | N/A |
| Operating Expenses | 14,353 | 12,595 | 5,700 | 3,237 | 2,740 |
| Operating Income | -12,814 | -10,906 | -4,595 | -2,953 | -2,740 |
| Interest Expense | 2,751 | 699 | 526 | 1,725 | 654 |
| Pre-tax Income | -15,565 | -11,605 | -5,121 | -4,678 | -3,394 |
| Net Income Continuous | -15,565 | -11,605 | -5,121 | -4,678 | -3,394 |
| Net Income | $-15,565 | $-11,605 | $-5,121 | $-4,678 | $-3,394 |
| EPS Basic Total Ops | -0.75 | -1.27 | -0.56 | -0.52 | -0.38 |
| EPS Basic Continuous Ops | -0.75 | -1.27 | -0.56 | -0.52 | -0.38 |
| EPS Diluted Total Ops | -0.75 | -1.27 | -0.56 | -0.52 | -0.38 |
| EPS Diluted Continuous Ops | -0.75 | -1.27 | -0.56 | -0.52 | -0.38 |
| EBITDA(a) | $-12,418 | $-10,489 | $-4,269 | $-2,495 | $-2,740 |